Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-beta1 signaling in endothelial cells - Albiñana, V; Sanz-Rodriguez, F; Recio-Poveda, L (Mol Pharmacol, 2011)
et al.